BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 411 filers reported holding BIO-TECHNE CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,901,748 | -1.1% | 218,918 | +18.6% | 0.11% | +2.8% |
| Q2 2023 | $15,071,184 | +23.5% | 184,628 | +12.2% | 0.11% | +18.5% |
| Q1 2023 | $12,203,365 | +109484.8% | 164,488 | +22.4% | 0.09% | +7.0% |
| Q4 2022 | $11,136 | -99.9% | 134,360 | +342.6% | 0.09% | +19.4% |
| Q3 2022 | $8,621,000 | -22.5% | 30,355 | -5.4% | 0.07% | -15.3% |
| Q2 2022 | $11,118,000 | -17.1% | 32,075 | +3.6% | 0.08% | 0.0% |
| Q1 2022 | $13,413,000 | +2.9% | 30,975 | +22.9% | 0.08% | +7.6% |
| Q4 2021 | $13,034,000 | +17.3% | 25,195 | +9.9% | 0.08% | +11.3% |
| Q3 2021 | $11,111,000 | -4.0% | 22,930 | -10.8% | 0.07% | -30.4% |
| Q2 2021 | $11,572,000 | +6.5% | 25,701 | -9.7% | 0.10% | -2.9% |
| Q1 2021 | $10,866,000 | +17.3% | 28,449 | -2.5% | 0.10% | +7.1% |
| Q4 2020 | $9,264,000 | +16.0% | 29,173 | -9.5% | 0.10% | +15.3% |
| Q3 2020 | $7,985,000 | -7.6% | 32,234 | -1.5% | 0.08% | -12.4% |
| Q2 2020 | $8,638,000 | +8.7% | 32,712 | -22.0% | 0.10% | -10.2% |
| Q1 2020 | $7,947,000 | -39.0% | 41,912 | -29.3% | 0.11% | -22.3% |
| Q4 2019 | $13,020,000 | +4.6% | 59,312 | -6.8% | 0.14% | +0.7% |
| Q3 2019 | $12,447,000 | -9.7% | 63,612 | -3.8% | 0.14% | -10.4% |
| Q2 2019 | $13,784,000 | +0.5% | 66,112 | -4.3% | 0.15% | 0.0% |
| Q1 2019 | $13,722,000 | +5.0% | 69,112 | -23.5% | 0.15% | -3.8% |
| Q4 2018 | $13,070,000 | -29.1% | 90,312 | 0.0% | 0.16% | -12.1% |
| Q3 2018 | $18,434,000 | +6.9% | 90,312 | -22.5% | 0.18% | +4.6% |
| Q2 2018 | $17,241,000 | -2.0% | 116,535 | 0.0% | 0.17% | -4.4% |
| Q1 2018 | $17,601,000 | +16.6% | 116,535 | 0.0% | 0.18% | +21.3% |
| Q4 2017 | $15,097,000 | – | 116,535 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |